Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/27/2024 10:52:21 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 847
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68934
Yaaa I know and will still be vigilant in staying
NotRichYet2
03/10/2021 9:23:38 AM
68933
I see our resident idiot has been watching Full
(1)
scgmck1
03/10/2021 8:59:41 AM
68931
Thanks! I love to see third party votes of
(6)
Ultimate
03/10/2021 8:01:59 AM
68930
$IPIX ICYMI
(3)
TonyCorvette
03/10/2021 7:47:40 AM
68929
Brilacidin found to have a high theoretical viral
(3)
kerdom
03/10/2021 7:42:39 AM
68928
Attached is an article regarding the
(6)
petemantx
03/09/2021 6:01:52 PM
68927
Today I got my first of two vaccine shots
NotRichYet2
03/09/2021 4:10:44 PM
68926
I hope that you are right. But since the DTCC is
(2)
thefamilyman
03/09/2021 2:30:19 PM
68925
I thought that this was a proposed rule change
(1)
thefamilyman
03/09/2021 1:55:21 PM
68923
Correct DTCC IS TRYING to cover its arse as is
(9)
AlanC
03/09/2021 10:51:02 AM
68922
I would encourage everyone to watch the YouTube
(5)
DrTim
03/09/2021 10:11:01 AM
68920
I am going to break my own rule just this one
(13)
Mo
03/08/2021 10:43:40 PM
68919
Love it. GME has them by the short hairs. Fun to
(7)
AlanC
03/08/2021 7:38:09 PM
68917
Here is a you tube video my son sent me this
(3)
falcon74
03/08/2021 2:49:43 PM
68916
Just saw Fauci on TV explaining how they are now
(4)
Chemdeps
03/08/2021 11:44:44 AM
68915
SI-426
(1)
crashco
03/08/2021 11:02:37 AM
68914
Brilacidin has a history of success in human
(4)
mtnman213
03/08/2021 9:29:25 AM
68913
This is big news and imho will cause those that
(5)
AlanC
03/08/2021 8:11:22 AM
68912
Clinical Trials Site Updated. Added site, Russia
(2)
crashco
03/08/2021 6:38:24 AM
68911
This week's clinical trial failures for
(12)
Drano
03/07/2021 6:40:58 PM
68908
Since the PR came out Friday mid-day, it is
(8)
Chemdeps
03/07/2021 3:25:59 PM
68906
Good point. I still think that even if BARDA is
(9)
Ultimate
03/06/2021 1:04:02 PM
68903
Let's not forget that the BARDA grant program for
(5)
Drano
03/06/2021 11:25:14 AM
68902
A subtle little "tell" but, hey, PRs are drafted,
(4)
crashco
03/06/2021 9:40:04 AM
68901
Leo used the word countermeasure in this
(9)
Ultimate
03/06/2021 9:18:30 AM
68900
Here is an article listing NASDQ listing
petemantx
03/05/2021 5:48:11 PM
68899
Shoulda asked for 10k or even 20k at .24. Bet the
(6)
scgmck1
03/05/2021 5:46:41 PM
68898
Not sure how long it takes to file and be
Commando911
03/05/2021 4:28:27 PM
68897
How are they still otc
zdubble17
03/05/2021 4:10:34 PM
68896
See ONPH six month chart, significantly lower
Commando911
03/05/2021 4:05:10 PM
68895
Same idiot sold me 5000 shares at .25 -
(1)
angeli
03/05/2021 1:24:01 PM
68894
Colchicine doesn't work (and it can have bad side
(2)
Drano
03/05/2021 1:01:05 PM
68893
Those 2 studies were closed for "futility." We
(5)
Drano
03/05/2021 12:48:55 PM
68892
Brilacidin PhaseII is active. Can it succeed
(1)
crashco
03/05/2021 12:40:18 PM
68891
Very glad to see this! Finally! IPIX
kerdom
03/05/2021 12:18:51 PM
68890
Some idiot just sold me another 10,000+ shares. I
(9)
scgmck1
03/05/2021 12:03:56 PM
68889
Clinical Trial PR. Recruitment and Enrollment
(3)
bettingbig
03/05/2021 11:38:00 AM
68885
As important as Brilacidin is going to be I would
(11)
petemantx
03/05/2021 8:47:57 AM
68884
Im looking at this trial and am very excited
(7)
zdubble17
03/05/2021 8:47:14 AM
68883
Well said! I think this is excellent news! I am
(7)
Ultimate
03/05/2021 8:23:45 AM
68882
For those who see The Prince written between
(10)
crashco
03/05/2021 8:09:46 AM
68881
Trial now listed on clinicaltrials.gov
(11)
Patchesohoulihan
03/05/2021 7:00:20 AM
68874
Good question since they all know though they
(2)
AlanC
03/04/2021 1:30:04 PM
68867
I agree with you on this. I am also curious as to
(3)
thefamilyman
03/04/2021 10:14:15 AM
68866
Buy them when they are cheap! Hold strong
(5)
pizza
03/04/2021 9:56:07 AM
68864
Added a few more at .30 this
(5)
TMAN
03/04/2021 9:47:14 AM
68862
the Next hearing- The U.S. House Committee on
(8)
AlanC
03/04/2021 9:30:58 AM
68861
A good contra-indicator... many nasty caustic and
(4)
steelyeye
03/03/2021 9:41:01 PM
68859
Glad to see you still punching Kelt. Keep up the
(5)
scgmck1
03/03/2021 2:33:04 PM
68858
The criminals were caught red handed in the GME
(9)
AlanC
03/03/2021 2:21:16 PM
< Previous
Next >
Recent Articles
Zevia (NYSE: ZVIA) Achieves NYSE Compliance with Stock Price
Exploring the Potential of the Expanding Lithium Carbonate Market
Southland Holdings Secures $160 Million Loan for Growth
CytoMed Therapeutics Expands Biologics Strategy Through Acquisition
Ionis Pharmaceuticals Advances Donidalorsen for HAE Treatment
Groundbreaking Advancements in Kidney Cancer Detection by Telix
Aldeyra Therapeutics Advances Dry Eye Treatment with Resubmission
Plymouth Industrial REIT's Q3 2024 Update: Strong Leasing Results
Hims & Hers Faces Challenges as FDA Confirms Drug Availability
Stallion Uranium Enhances Exploration with HeliSam Survey Insights
BofA Insights: Anticipated AI Features to Boost iPhone 16 Sales
Gain Therapeutics CEO to Highlight Innovations at Key Events
Key Issues Affecting Intel's Future and Investor Confidence
Euro Manganese Welcomes New Director to Enhance Leadership Team
Apollo Silver Secures $10 Million to Boost Silver Exploration
Stingray Group Prepares for Its Upcoming Financial Report
Constellium Earns Prestigious Supplier Recognition for CSR
Anticipating Green Thumb Industries' Upcoming Earnings Call
NFI Group's Alexander Dennis Expands Zero-Emission Fleet
Elevating Fan Experience: Xtract One Partners with Cavaliers
Microbix Biosystems Inc. Secures Key EU Regulatory Compliances
Alta Equipment Group Declares Preferred Stock Dividend Boost
Better Choice Company Announces Shareholder Update Call Details
Prospect Capital Marks Two Decades of Success in Investment
Wesdome Gold Welcomes Philip C. Yee to Board as Director
Brown & Brown, Inc. Expands with The Canopy Group Acquisition
Eton Pharmaceuticals Enhances Pediatric Portfolio with Increlex Acquisition
Exploring Alliance Trust PLC’s Recent Net Asset Value Insights
Pharvaris Shares Insights on Deucrictibant for HAE Management
Wesdome Gold Mines Welcomes Philip C. Yee as Director and Chair
AngioDynamics Achieves Positive Growth in Q1 Fiscal 2025
Eton Pharmaceuticals Expands Pediatric Portfolio with Increlex
Sonic Automotive Prepares for Q3 Financial Results Release
Brown & Brown, Inc. Enhances Portfolio with Canopy Group Acquisition
Avangrid Secures Major Federal Funding for Renewable Energy Project
IGT Enhances Lottery Solutions with New Contract Extension
AECOM's Strategic Role in Enhancing Ontario's Housing Infrastructure
Pharvaris to Showcase Deucrictibant Data at Upcoming Workshop
Housing Market Update: Surge in New Listings & Reduced Prices
KITS Eyecare Delivers Impressive Preliminary Q3 Results
Piper Sandler Confirms Target for Tyra Biosciences Growth
Peloton's Strategic Shift and Future Growth Prospects
FAMU Launches Historic Trimble Technology Lab for Students
Exploring the Future of Green Methanol Shipping Industry
Brown & Brown Expands Horizon with Latest Acquisition Move
CNX Resources Reveals Third Quarter Results and Upcoming Call
Eton Pharmaceuticals Acquires Increlex to Boost Rare Disease Treatment
Avangrid's $425 Million Contract Fuels Renewable Energy Expansion
GFL Environmental Inc. Declares Cash Dividend for Shareholders
Legal-Bay Enhances Website for Swift Settlement Funding